loaderimg
image

St. Teresa was founded in 2010 to commercialize an innovative technology developed at Virginia Commonwealth University (VCU) in collaboration with the Henry Jackson Foundation for the Advancement of Military Medicine. St Teresa has produced the next generation of disruptive products by combining medicinals in a medical device to reduce uncontrolled bleeding. The unique solution to fibrin sealant hemostasis is its CONTACT NANO-LIGATION™ soft matter technology, SurgiClot.

We are focused on treating surgical bleeding.

Company’s Keywords:

nanotechnology, hemostasis, cancellous bone healing, soft matter technology, bleeding

Q How Many Employees Does This Company Have?

<5

Q Which Industry Does This Company Belong To?

Q What Is the Annual Income?

<5000000

Q What Is the Technology of All the Company’s Website?

Q What Year Was the Company Founded?

<2010

Rate us and Write a Review

Your review is recommended to be at least 140 characters long

image

building Own or work here? Claim Now! Claim Now!

imageYour request has been submitted successfully.

image